Cargando…

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation

AIM: One of the most anticipated adverse effects of warfarin is over-anticoagulation. There is little to no evidence on the treatment that should be administered in patients with an international normalized ratio (INR)≥10. The primary outcome of this study is to analyze the effects of various treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	İslam, Mehmet Muzaffer, Ademoğlu, Enis, Uygun, Cemrenur, Delipoyraz, Melike, Satıcı, Merve Osoydan, Aksel, Gökhan, Eroğlu, Serkan Emre, Özdemir, Serdar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	African Federation for Emergency Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852257/ https://www.ncbi.nlm.nih.gov/pubmed/36700167 http://dx.doi.org/10.1016/j.afjem.2022.12.001

Ejemplares similares

Predictors of 7-day symptomatic hemorrhagic transformation in patients with acute ischemic stroke and proposal of a novel screening tool: A retrospective cohort study
por: Islam, Mehmet Muzaffer, et al.
Publicado: (2023)

The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
por: Satici, Merve Osoydan, et al.
Publicado: (2022)

Trauma-related oral lesions; Angina bullosa haemorrhagica: a rare case presentation
por: Satici, Merve Osoydan, et al.
Publicado: (2022)

Diagnostic and prognostic values of cerebral oxygen saturations measured by INVOS™ in patients with ischemic and hemorrhagic cerebrovascular disease
por: Eroğlu, Serkan Emre, et al.
Publicado: (2019)

A Rare Case of Metformin Intoxication with Mortal Course
por: Osoydan Satici, Merve, et al.
Publicado: (2020)

Early predictors of mortality for moderate to severely ill patients with Covid-19
por: Aksel, Gökhan, et al.
Publicado: (2021)

A Rare Cause of ST-Segment Elevation Myocardial Infarction in COVID-19: MINOCA Syndrome
por: Eroglu, Serkan Emre, et al.
Publicado: (2021)

The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
por: Satici, Merve Osoydan, et al.
Publicado: (2023)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Tetanus in refugee patients: Two cases and review of the literature
por: Aksel, Gökhan, et al.
Publicado: (2019)

Is frontal QRS-T angle a valid predictor of COVID-19 severity?
por: Özdemir, Serdar, et al.
Publicado: (2022)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

Effect of the COVID-19 Pandemic on Emergency Department Presentations with Mushroom Poisoning: A Report from Turkey
por: Özdemir, Serdar, et al.
Publicado: (2022)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021)

A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR
por: Ur Rahman, Saad
Publicado: (2023)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

Iatrogenic subcutaneous emphysema and pneumomediastinum due to dental extraction procedure
por: Ozdemir, Serdar, et al.
Publicado: (2020)

Predictors for INR-control in a well-managed warfarin treatment setting
por: Björck, Fredrik, et al.
Publicado: (2018)

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
por: Arbring, Kerstin, et al.
Publicado: (2013)

Optimal INR level for warfarin therapy after mechanical mitral valve replacement
por: Kamthornthanakarn, Itthidet, et al.
Publicado: (2019)

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users
por: Dumas, Stephanie, et al.
Publicado: (2016)

Enoxaparin-sodium/heparin/warfarin: Heparin-induced thrombocytopenia and elevated INR: case report
Publicado: (2021)

Determining INR Awareness of the Patients who Use Warfarin and Rates of Achieving the Target Dosage
por: Demir, Nazan, et al.
Publicado: (2020)

Does prophylactic antibiotic administration for tooth extraction affect PT-INR in patients taking warfarin?
por: Iwata, Eiji, et al.
Publicado: (2020)

Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures
por: Kampouraki, Emmanouela, et al.
Publicado: (2019)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Dynamic ‘Spot Sign’ Resolution following INR Correction in a Patient with Warfarin-Associated Intracerebral Hemorrhage
por: Chakraborty, S., et al.
Publicado: (2011)

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2014)

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
por: Watanabe, Norio, et al.
Publicado: (2017)

Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
por: Akamatsu, Hayato, et al.
Publicado: (2023)

Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases
por: Yetkin, Ufuk, et al.
Publicado: (2004)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
por: Haug, Kari Bente Foss, et al.
Publicado: (2008)

How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?
por: Kim, Jun Hyung, et al.
Publicado: (2009)

Effects of structured patient education on knowledge level and INR control of patients receiving warfarin: Randomized Controlled Trial
por: Baysal, Ebru, et al.
Publicado: (2018)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
por: Luengsupabul, Sirote, et al.
Publicado: (2020)

Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients
por: Al-Momany, Nairooz H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ujcghkn1k4qarafkt18qp3fa2